ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 256 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27 | -93.1% | 4,711 | +375.4% | 0.00% | 0.0% |
| Q4 2022 | $393 | -99.9% | 991 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $388,000 | +19.0% | 1,016 | +16.2% | 0.00% | 0.0% |
| Q2 2022 | $326,000 | +22.1% | 874 | +5.0% | 0.00% | +50.0% |
| Q1 2022 | $267,000 | +23.0% | 832 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -17.2% | 835 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $262,000 | -70.5% | 895 | -69.1% | 0.00% | -60.0% |
| Q2 2021 | $889,000 | +4.3% | 2,894 | +0.6% | 0.01% | 0.0% |
| Q1 2021 | $852,000 | +7.6% | 2,876 | +12.9% | 0.01% | 0.0% |
| Q4 2020 | $792,000 | +30.9% | 2,547 | +5.4% | 0.01% | +25.0% |
| Q3 2020 | $605,000 | +5.2% | 2,416 | +9.0% | 0.00% | 0.0% |
| Q2 2020 | $575,000 | +86.7% | 2,216 | +5.2% | 0.00% | +33.3% |
| Q1 2020 | $308,000 | – | 2,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |